{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,14]],"date-time":"2025-10-14T06:56:52Z","timestamp":1760425012511},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3321,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1365-2133.1995.tb02765.x","type":"journal-article","created":{"date-parts":[[2010,7,21]],"date-time":"2010-07-21T15:43:29Z","timestamp":1279727009000},"page":"814-815","source":"Crossref","is-referenced-by-count":7,"title":["Toxic epidermal necrolysis (Lyell syndrome) following famotidine administration"],"prefix":"10.1093","volume":"133","author":[{"given":"M.","family":"Brunner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Vardarman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Goldermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Goerz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Niederau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.F.","family":"Merk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Scharffetter-Kochanek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2006,7,29]]},"reference":[{"issue":"Suppl.","key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3109\/00365528709090138","article-title":"Famotidine: postmarketsing clinical experience","volume":"134","author":"Saigenji","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/978-3-642-46717-2_38","volume-title":"New Trends in Allergy","volume":"3","author":"Merk","year":"1991"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0190-9622(91)70176-3","article-title":"Toxic cepidermal necrolys:s: A review","volume":"25","author":"Avakian","year":"1991","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1001\/archderm.1993.01680250078010","article-title":"Cutaneous T-cel recruitment in toxic epidermal nucrolysis. Further evidence of CD8+ lymphocyte involvement","volume":"129","author":"Correia","year":"1993","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB5|cit5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/1523-1747.ep12371697","article-title":"Predominance of epidermal CD8+ T lymphocytes in bullous cutaneous reactions caused by \u03b2-lactam in antibiotics","volume":"101","author":"Hertl","year":"1993","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1001\/archderm.1985.01660120074023","article-title":"Plasma-pheresis in severe drug-induced toxic epidermal necrolysis","volume":"121","author":"Kamanabroo","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1445-5994.1983.tb02681.x","article-title":"Stevens-Johnson syndrome: Was it cimetidine","volume":"13","author":"Guan","year":"1983","journal-title":"Aust NZ J Med"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S0140-6736(78)91910-4","article-title":"Stevens-Johnson syndrome during treatment with cimetidine","volume":"ii","author":"Ahmed","year":"1978","journal-title":"Lancet"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB9|cit9","first-page":"418","article-title":"Die Behandlung der leichten bis mittelschnweren Refluxosophagitis mit dem H2-Blucker Famotidin","volume":"142","author":"Kratochvil","year":"1992","journal-title":"Wien Medt Wochenschr"},{"issue":"Suppl.l","key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB10|cit10","first-page":"9","article-title":"Pharmacology of H2-receptor antagonists: an overview","volume":"17","author":"Schunack","year":"1989","journal-title":"J Int Med Res"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2036.1991.tb00531.x","article-title":"Famotidine (20 mg) b.d. relieves gastrooesophageal reflux symptoms in patients without erosive oesophagitis. Famotidine\/GERD Investigation Group","volume":"5","author":"Robinsen","year":"1991","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB12|cit12","first-page":"493","volume-title":"What are the differences between the H2-rcceptor antagonists","volume":"1","author":"Schunack","year":"1957"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1177\/106002808802201209","article-title":"Famotidine-associated mental confusion in elderly patients","volume":"22","author":"Henann","year":"1988","journal-title":"Drug Intell clin Pharm"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/j.1875-9114.1987.tb03534.x","article-title":"Clinically important adverse effects and drug interactions with H2-receptor antagonists: an update","volume":"7","author":"Sax","year":"1987","journal-title":"Pharmacotherapy"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB15|cit15","first-page":"647","article-title":"Effects ofshort- and long-term administrations of famotidine and ranitidine on some pituitary, sexual and thyroid hormones","volume":"13","author":"Corinaldesi","year":"1987","journal-title":"Drugs Exp clin Res"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB16|cit16","first-page":"507","article-title":"Possible famotidine-induced thrombocytopenia","volume":"23","author":"Comer","year":"1989","journal-title":"DICF"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/106002809202600224","article-title":"Thrombocytopenia associated with famotidine in a hemophillac","volume":"26","author":"Humphries","year":"1992","journal-title":"Ann Pharmacother"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB18|cit18","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1177\/106002809102500622","article-title":"Probable famotidine-induced thrombocytopenia","volume":"25","author":"Zimmermann","year":"1991","journal-title":"DICP"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB19|cit19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/BF01738302","article-title":"The growth capacity of hematopoietic progenitor cells in severe neutropenia induced by famaotidine","volume":"64","author":"Liersch","year":"1992","journal-title":"Ann Hematol"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB20|cit20","first-page":"234","article-title":"Vasculltis leucocitoclastica y famotidina","volume":"95","author":"Andreo","year":"1990","journal-title":"Med din Barc"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB21|cit21","first-page":"436","article-title":"Famotidine in the management of duodenal ulcer: an analysis of multicenter findings worldwide","volume":"10","author":"Reynolds","year":"1988","journal-title":"Clin Ther"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB22|cit22","first-page":"408","article-title":"Therapie peptischer Ulzera mit Famotidin. Erfahrungsbericht einer offenen klinischen Studie","volume":"142","author":"Dragosics","year":"1992","journal-title":"Wien Med Wochenschr"},{"key":"10.1111\/j.1365-2133.1995.tb02765.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1600-0536.1990.tb01600.x","article-title":"Contact eczema from famotidine","volume":"22","author":"Monteseirin","year":"1990","journal-title":"Contact Dermatitis"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-2133.1995.tb02765.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1365-2133.1995.tb02765.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:59:34Z","timestamp":1676383174000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/133\/5\/814\/6681670"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,7,29]]},"references-count":23,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1365-2133.1995.tb02765.x","relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,7,29]]}}}